Cytomegalovirus seropositivity is associated with reduced risk of multiple sclerosis—a presymptomatic case–control study
Year: 2021
Type: article
Study design: Observational Study
Abstract: BACKGROUND AND PURPOSE: Epstein-Barr virus (EBV) and human herpesvirus 6A (HHV-6A) are associated with increased risk of multiple sclerosis (MS). Conversely, infection with cytomegalovirus (CMV) has been suggested to reduce the risk of MS but supporting data from presymptomatic studies are lacking. Here, it was sought to increase the understanding of CMV in MS aetiology. METHODS: A nested case-control study was performed with presymptomatically collected blood samples identified through crosslinkage of MS registries and Swedish biobanks. Serological antibody response against CMV, EBV and HHV-6A was determined using a bead-based multiplex assay. Odds ratio (OR) with 95% confidence interval (CI) for CMV seropositivity as a risk factor for MS was calculated by conditional logistic regression and adjusted for EBV and HHV-6A seropositivity. Potential interactions on the additive scale were analysed by calculating the attributable proportion due to interaction (AP). RESULTS: Serum samples from 670 pairs of matched cases and controls were included. CMV seropositivity was associated with a reduced risk for MS (OR = 0.70, 95% CI 0.56-0.88, p = 0.003). Statistical interactions on the additive scale were observed between seronegativity for CMV and seropositivity against HHV-6A (AP 0.34, 95% CI 0.06-0.61) and EBV antigen EBNA-1 (amino acid 385-420) at age 20-39 years (AP 0.37, 95% CI 0.09-0.65). CONCLUSIONS: Cytomegalovirus seropositivity is associated with a decreased risk for MS. The protective role for CMV infection in MS aetiology is further supported by the interactions between CMV seronegativity and EBV and HHV-6A seropositivity.
Source: European Journal of Neurology
DOI: 10.1111/ene.14961
Authors: Viktor Grut(Formal analysis, Writing – original draft, Writing – review & editing), Martin Biström(Data curation, Formal analysis, Supervision, Writing – original draft, Writing – review & editing), Jonatan Salzer(Formal analysis, Supervision, Writing – original draft, Writing – review & editing), Pernilla Stridh, Daniel Jons(Investigation, Writing – review & editing), Rasmus Gustafsson(Investigation, Writing – review & editing), Anna Fogdell‐Hahn(Investigation, Writing – review & editing), Jesse Huang(Investigation, Writing – review & editing), Nicole Brenner(Formal analysis, Investigation, Writing – review & editing), Julia Butt(Investigation, Writing – review & editing), Noemi Bender(Investigation, Writing – review & editing), Anna Lindam(Formal analysis, Software, Writing – review & editing), Lucia Alonso‐Magdalena(Validation, Writing – review & editing), Martin Gunnarsson(Validation, Writing – review & editing), Magnus Vrethem(Validation, Writing – review & editing), Tomas Bergström(Formal analysis, Writing – review & editing), Oluf Andersen(Investigation, Writing – review & editing), Ingrid Kockum(Investigation, Writing – review & editing), Tim Waterboer(Investigation, Writing – review & editing), Tomas Olsson(Investigation, Writing – review & editing), Peter Sundström(Conceptualization, Formal analysis, Funding acquisition, Supervision, Writing – original draft, Writing – review & editing)
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $4,100
Awards: Multiple manifestations of genetic and non-genetic factors in Multiple Sclerosis disentangled with a multi-omics approach to accelerate personalised medicine, The role of environment in Multiple Sclerosis etiology, Understanding the epidemiology of respiratory syncytial virus infection as a groundwork for antiviral treatment
OpenAlex ID: W3169599583
